  |
|
In this first acute clinical study, 6 healthy males were given 30% Salba® enriched white bread and standard white bread as a control food.
Following consumption of the experimental bread with Salba®, venous blood samples were tested on the participants over a 2-hour period of time for blood glucose and insulin concentrations. The results were as follows:
 |
White bread enriched with 30% Salba® lowers after-meal plasma glucose at 90 and 120 minutes after ingestion of the experimental bread with Salba™ compared with white bread control. |
|
White bread enriched with 30% Salba® lowers after-meal plasma insulin at 30 and 45 minutes after ingestion of experimental bread compared with white bread control. |
|
It has been concluded that in comparison with standard white bread, Salba® enriched bread improves overall after-meal insulin sensitivity (lower glucose with less insulin required) indicating its possible use in individuals with metabolic syndrome, otherwise healthy obese patients, as well as individuals already suffering from Type 2 Diabetes. |
|
|
 |
|
|
